These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 16410746)
21. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114 [TBL] [Abstract][Full Text] [Related]
22. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658 [TBL] [Abstract][Full Text] [Related]
23. Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine. Rei N; Valente CA; Vaz SH; Farinha-Ferreira M; Ribeiro JA; Sebastião AM PLoS One; 2022; 17(12):e0272104. PubMed ID: 36516126 [TBL] [Abstract][Full Text] [Related]
24. Gene and protein therapies utilizing VEGF for ALS. Keifer OP; O'Connor DM; Boulis NM Pharmacol Ther; 2014 Mar; 141(3):261-71. PubMed ID: 24177067 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System. Silva-Hucha S; Pastor AM; Morcuende S Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467517 [TBL] [Abstract][Full Text] [Related]
26. Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Devos D; Moreau C; Lassalle P; Perez T; De Seze J; Brunaud-Danel V; Destée A; Tonnel AB; Just N Neurology; 2004 Jun; 62(11):2127-9. PubMed ID: 15184633 [TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients. Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676 [TBL] [Abstract][Full Text] [Related]
28. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986 [TBL] [Abstract][Full Text] [Related]
29. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Chen Y; Guan Y; Zhang Z; Liu H; Wang S; Yu L; Wu X; Wang X Neurol Res; 2012 May; 34(4):390-9. PubMed ID: 22643084 [TBL] [Abstract][Full Text] [Related]
30. scAAV9-VEGF prolongs the survival of transgenic ALS mice by promoting activation of M2 microglia and the PI3K/Akt pathway. Wang Y; Duan W; Wang W; Di Wen ; Liu Y; Liu Y; Li Z; Hu H; Lin H; Cui C; Li D; Dong H; Li C Brain Res; 2016 Oct; 1648(Pt A):1-10. PubMed ID: 27392886 [TBL] [Abstract][Full Text] [Related]
31. VEGF and ALS. Sathasivam S Neurosci Res; 2008 Oct; 62(2):71-7. PubMed ID: 18656504 [TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151 [TBL] [Abstract][Full Text] [Related]
33. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas. Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
35. Synaptophysin in spinal anterior horn in aging and ALS: an immunohistological study. Cruz-Sánchez FF; Moral A; Rossi ML; Quintó L; Castejón C; Tolosa E; de Belleroche J J Neural Transm (Vienna); 1996; 103(11):1317-29. PubMed ID: 9013418 [TBL] [Abstract][Full Text] [Related]
36. Single chain precursor prohaptoglobin promotes angiogenesis by upregulating expression of vascular endothelial growth factor (VEGF) and VEGF receptor2. Oh MK; Park HJ; Lee JH; Bae HM; Kim IS FEBS Lett; 2015 Apr; 589(9):1009-17. PubMed ID: 25775978 [TBL] [Abstract][Full Text] [Related]
37. Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse. Nalbandian A; Dettin L; Dym M; Ravindranath N Biol Reprod; 2003 Sep; 69(3):985-94. PubMed ID: 12773425 [TBL] [Abstract][Full Text] [Related]
38. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408 [TBL] [Abstract][Full Text] [Related]
39. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer. Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886 [TBL] [Abstract][Full Text] [Related]